Head of Research, IPOs & Placements, Aequitas Research

Sumeet Singh

Head of Research, IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

LG Energy Solution / Equity Capital Markets

<ul>
<li>In this note, we will take a look at the Asia Pacific IPO pipeline for 2023, specifically for India, Asia-linked ADRs, Korea, Japan and ASEAN.</li>
<li>This list has been compiled on a best effort basis from tracking the company filings and through various other sources.</li>
<li>The deals you see in this note are only a part of our full IPO pipeline tracker. Feel free to drop us a message for additional information on these IPOs.</li>
</ul>


In this note, we will take a look at the Asia Pacific IPO pipeline for 2023, specifically for India, Asia-linked ADRs, Korea, Japan and ASEAN.
This list has been compiled on a best effort basis from tracking the company filings and through various other sources.
The deals you see in this note are only a part of our full IPO pipeline tracker. Feel free to drop us a message for additional information on these IPOs.


Aequitas 2023 Asia IPO Pipeline - India, ADRs, Korea, Japan and ASEAN

Fintech & EM-focused Analyst, KT Capital Group

Alec Tseung

Fintech & EM-focused Analyst

Private Capital Markets

Kyobo Life Insurance Co Ltd / Private Capital Markets

<ul>
<li>News and rumors about a potential IPO of <a href="https://www.smartkarma.com/entities/kyobo-life-insurance-co-ltd" target="_blank" data-smartkarma-citation="entities:33146:1" rel="noopener">Kyobo Life Insurance Co Ltd (KYLINZ KS)</a> resurfaced given the strong performance of the equity market in Korea.</li>
<li>Korean life insurance's sector outlook remains uncertain given the country's prolonged low interest rate environment and the upcoming regulatory and accounting standard changes.</li>
<li> Kyobo Life's current shareholding structure is dominated by private equity and other institutional investors which are actively looking to exit.</li>
<li>Its implied value per share based on peers' trading multiples is unlikely to generate a decent recent for these institutional investors.</li>
<li>Kyobo Life's IPO plan remains very challenging.</li>
</ul>


News and rumors about a potential IPO of Kyobo Life Insurance Co Ltd (KYLINZ KS) resurfaced given the strong performance of the equity market in Korea.
Korean life insurance's sector outlook remains uncertain given the country's prolonged low interest rate environment and the upcoming regulatory and accounting standard changes.
 Kyobo Life's current shareholding structure is dominated by private equity and other institutional investors which are actively looking to exit.
Its implied value per share based on peers' trading multiples is unlikely to generate a decent recent for these institutional investors.
Kyobo Life's IPO plan remains very challenging.


Kyobo Life: Challenging Sector Outlook with Most Existing Shareholders Hoping to Get Out

South Korea

Kyobo Life Insurance Co., Ltd offers life insurance services. The Company provides health, pension, accident insurance, and other insurance services. Kyobo Life Insurance offers services throughout South Korea.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Aequitas 2023 Asia IPO Pipeline - India, ADRs, Korea, Japan and ASEAN

In this note, we will take a look at the Asia Pacific IPO pipeline for 2023, specifically for India, Asia-linked ADRs, Korea, Japan and ASEAN.

Sumeet Singh

Kyobo Life: Challenging Sector Outlook with Most Existing Shareholders Hoping to Get Out

Kyobo Life's potential IPO remains difficult given the uncertain sector outlook and conflicting shareholders' interests.

Alec Tseung